Asthmanefrin

GPTKB entity

Statements (54)
Predicate Object
gptkbp:instance_of gptkb:superhero
gptkbp:activities adrenergic agonist
gptkbp:approves gptkb:FDA
gptkbp:brand gptkb:Asthmanefrin
gptkbp:clinical_trial Phase 3
NC T01234567
as needed for asthma symptoms
gptkbp:contraindication severe asthma attacks
gptkbp:current_use chronic obstructive pulmonary disease
gptkbp:dosage_form metered-dose inhaler
gptkbp:education how to use inhaler
recognizing asthma symptoms
when to seek emergency care
gptkbp:feedback generally well tolerated
effective for quick relief
gptkbp:formulation aerosol
liquid solution
https://www.w3.org/2000/01/rdf-schema#label Asthmanefrin
gptkbp:indication relief of bronchospasm
gptkbp:ingredients racepinephrine
gptkbp:interacts_with MAO inhibitors
beta-blockers
tricyclic antidepressants
gptkbp:is_available_on prescription medication
gptkbp:is_used_for asthma treatment
gptkbp:manager inhalation
gptkbp:manufacturer Medi Natura
gptkbp:marketed_as gptkb:Australia
gptkb:United_Kingdom
gptkb:United_States
gptkb:Native_American_tribe
gptkbp:packaging aerosol canister
gptkbp:pharmacokinetics rapid onset of action
gptkbp:population adults and children over 4 years
gptkbp:provides_information_on National Asthma Education and Prevention Program
gptkbp:regulatory_compliance FDA approval in 2013
gptkbp:research asthma management strategies
gptkbp:safety_features post-marketing surveillance
not for use in patients with heart disease
gptkbp:scholarships consult healthcare provider before use
gptkbp:shelf_life 24 months
gptkbp:side_effect dizziness
headache
nausea
nervousness
tremors
increased heart rate
gptkbp:storage room temperature
gptkbp:supply_chain available at pharmacies
gptkbp:treatment enhanced quality of life
improved lung function
reduced asthma attacks
gptkbp:bfsParent gptkb:formoterol
gptkbp:bfsLayer 5